Literature DB >> 23893242

Scaffold attachment factor B1 regulates the androgen receptor in concert with the growth inhibitory kinase MST1 and the methyltransferase EZH2.

N K Mukhopadhyay1, J Kim2, S You1, M Morello1, M H Hager3, W-C Huang1, A Ramachandran3, J Yang1, B Cinar1, M A Rubin4, R M Adam3, S Oesterreich5, D Di Vizio2, M R Freeman2.   

Abstract

The androgen receptor (AR) is a transcription factor that employs many diverse interactions with coregulatory proteins in normal physiology and in prostate cancer (PCa). The AR mediates cellular responses in association with chromatin complexes and kinase cascades. Here we report that the nuclear matrix protein, scaffold attachment factor B1 (SAFB1), regulates AR activity and AR levels in a manner that suggests its involvement in PCa. SAFB1 mRNA expression was lower in PCa in comparison with normal prostate tissue in a majority of publicly available RNA expression data sets. SAFB1 protein levels were also reduced with disease progression in a cohort of human PCa that included metastatic tumors. SAFB1 bound to AR and was phosphorylated by the MST1 (Hippo homolog) serine-threonine kinase, previously shown to be an AR repressor, and MST1 localization to AR-dependent promoters was inhibited by SAFB1 depletion. Knockdown of SAFB1 in androgen-dependent LNCaP PCa cells increased AR and prostate-specific antigen (PSA) levels, stimulated growth of cultured cells and subcutaneous xenografts and promoted a more aggressive phenotype, consistent with a repressive AR regulatory function. SAFB1 formed a complex with the histone methyltransferase EZH2 at AR-interacting chromatin sites in association with other polycomb repressive complex 2 (PRC2) proteins. We conclude that SAFB1 acts as a novel AR co-regulator at gene loci where signals from the MST1/Hippo and EZH2 pathways converge.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23893242      PMCID: PMC3934948          DOI: 10.1038/onc.2013.294

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  53 in total

Review 1.  Nuclear hormone receptor coregulators in action: diversity for shared tasks.

Authors:  D Robyr; A P Wolffe; W Wahli
Journal:  Mol Endocrinol       Date:  2000-03

Review 2.  Nuclear receptor coregulators: multiple modes of modification.

Authors:  Ola Hermanson; Christopher K Glass; Michael G Rosenfeld
Journal:  Trends Endocrinol Metab       Date:  2002-03       Impact factor: 12.015

Review 3.  Androgen receptor signaling in androgen-refractory prostate cancer.

Authors:  M E Grossmann; H Huang; D J Tindall
Journal:  J Natl Cancer Inst       Date:  2001-11-21       Impact factor: 13.506

4.  A novel androgen-regulated gene, PMEPA1, located on chromosome 20q13 exhibits high level expression in prostate.

Authors:  L L Xu; N Shanmugam; T Segawa; I A Sesterhenn; D G McLeod; J W Moul; S Srivastava
Journal:  Genomics       Date:  2000-06-15       Impact factor: 5.736

5.  The polycomb group protein EZH2 is involved in progression of prostate cancer.

Authors:  Sooryanarayana Varambally; Saravana M Dhanasekaran; Ming Zhou; Terrence R Barrette; Chandan Kumar-Sinha; Martin G Sanda; Debashis Ghosh; Kenneth J Pienta; Richard G A B Sewalt; Arie P Otte; Mark A Rubin; Arul M Chinnaiyan
Journal:  Nature       Date:  2002-10-10       Impact factor: 49.962

6.  Identification and characterization of a novel androgen receptor coregulator ARA267-alpha in prostate cancer cells.

Authors:  X Wang; S Yeh; G Wu; C L Hsu; L Wang; T Chiang; Y Yang; Y Guo; C Chang
Journal:  J Biol Chem       Date:  2001-08-16       Impact factor: 5.157

7.  SAFB2, a new scaffold attachment factor homolog and estrogen receptor corepressor.

Authors:  Steven M Townson; Klaudia M Dobrzycka; Adrian V Lee; Mamie Air; Wanleng Deng; Kaiyan Kang; Shiming Jiang; Noriyuki Kioka; Kai Michaelis; Steffi Oesterreich
Journal:  J Biol Chem       Date:  2003-03-26       Impact factor: 5.157

8.  Enhanced androgen receptor signaling correlates with the androgen-refractory growth in a newly established MDA PCa 2b-hr human prostate cancer cell subline.

Authors:  Takahito Hara; Kazuyo Nakamura; Hideo Araki; Masami Kusaka; Masuo Yamaoka
Journal:  Cancer Res       Date:  2003-09-01       Impact factor: 12.701

9.  Apoptotic phosphorylation of histone H2B is mediated by mammalian sterile twenty kinase.

Authors:  Wang L Cheung; Kozo Ajiro; Kumiko Samejima; Malgorzata Kloc; Peter Cheung; Craig A Mizzen; Alexander Beeser; Laurence D Etkin; Jonathan Chernoff; William C Earnshaw; C David Allis
Journal:  Cell       Date:  2003-05-16       Impact factor: 41.582

10.  Activation of Mst1 causes dilated cardiomyopathy by stimulating apoptosis without compensatory ventricular myocyte hypertrophy.

Authors:  Shimako Yamamoto; Guiping Yang; Daniela Zablocki; Jing Liu; Chull Hong; Song-Jung Kim; Sandra Soler; Mari Odashima; Jill Thaisz; Ghassan Yehia; Carlos A Molina; Atsuko Yatani; Dorothy E Vatner; Stephen F Vatner; Junichi Sadoshima
Journal:  J Clin Invest       Date:  2003-05       Impact factor: 14.808

View more
  11 in total

1.  Scaffold attachment factor B suppresses HIV-1 infection of CD4+ T cells by preventing binding of RNA polymerase II to HIV-1's long terminal repeat.

Authors:  Li Ma; Li Sun; Xia Jin; Si-Dong Xiong; Jian-Hua Wang
Journal:  J Biol Chem       Date:  2018-06-10       Impact factor: 5.157

2.  Overexpression of MYC and EZH2 cooperates to epigenetically silence MST1 expression.

Authors:  Gamze Kuser-Abali; Ahmet Alptekin; Bekir Cinar
Journal:  Epigenetics       Date:  2014-02-27       Impact factor: 4.528

Review 3.  Autophagy as a mechanism for anti-angiogenic therapy resistance.

Authors:  Ankush Chandra; Jonathan Rick; Garima Yagnik; Manish K Aghi
Journal:  Semin Cancer Biol       Date:  2019-08-28       Impact factor: 15.707

4.  Scaffold attachment factor B1: an intrinsic inhibitor of androgen receptor downregulated in prostate cancer.

Authors:  Haojie Huang
Journal:  Asian J Androl       Date:  2013-09-30       Impact factor: 3.285

5.  The phytochemical 3,3'-diindolylmethane decreases expression of AR-controlled DNA damage repair genes through repressive chromatin modifications and is associated with DNA damage in prostate cancer cells.

Authors:  Zoraya Palomera-Sanchez; Gregory W Watson; Carmen P Wong; Laura M Beaver; David E Williams; Roderick H Dashwood; Emily Ho
Journal:  J Nutr Biochem       Date:  2017-05-25       Impact factor: 6.048

6.  Scaffold attachment factor B2 (SAFB2)-null mice reveal non-redundant functions of SAFB2 compared with its paralog, SAFB1.

Authors:  Shiming Jiang; Tiffany A Katz; Jason P Garee; Francesco J DeMayo; Adrian V Lee; Steffi Oesterreich
Journal:  Dis Model Mech       Date:  2015-06-18       Impact factor: 5.758

7.  FUS interacts with nuclear matrix-associated protein SAFB1 as well as Matrin3 to regulate splicing and ligand-mediated transcription.

Authors:  Atsushi Yamaguchi; Keisuke Takanashi
Journal:  Sci Rep       Date:  2016-10-12       Impact factor: 4.379

8.  Prostate cancer diagnosis using epigenetic biomarkers, 3D high-content imaging and probabilistic cell-by-cell classifiers.

Authors:  Darko Stefanovski; George Tang; Kolja Wawrowsky; Raymond C Boston; Nils Lambrecht; Jian Tajbakhsh
Journal:  Oncotarget       Date:  2017-07-05

9.  Regulation and Role of EZH2 in Cancer.

Authors:  Hirohito Yamaguchi; Mien-Chie Hung
Journal:  Cancer Res Treat       Date:  2014-07-15       Impact factor: 4.679

Review 10.  Going beyond Polycomb: EZH2 functions in prostate cancer.

Authors:  Su H Park; Ka-Wing Fong; Ezinne Mong; M Cynthia Martin; Gary E Schiltz; Jindan Yu
Journal:  Oncogene       Date:  2021-08-04       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.